Company / Revenue per Share
PALVELLA THERAPEUTICS, INC. Revenue per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.57
FY2023
5-year range
$0.36 / $0.84
FY2019-FY2023
Trend
+60.2%
vs FY2022
Sector context
#117 of 154
Health Care
What the data says
PALVELLA THERAPEUTICS, INC.'s revenue per share of $0.57 is lower than 76% of companies in the Health Care sector (FY2023). Revenue per Share returned to growth in FY2023 after 3 years of decline, reaching $0.57.
Based on SEC 10-K filings.
0.57 in FY2023 with a 5-year CAGR of +0.5%.
Improved from $0.52 to $0.57 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -11.8%
- 5-Year CAGR
- +0.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 154This company $0.57 Sector average $10.35
▼
-94.5% below sector average
Key checks
Key Insights
- In FY2023, revenue per share increased 60.2% year-over-year.
- Ranks #117 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2019.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0.57 | +60.2% |
| FY2022 | $0.36 | -31.5% |
| FY2021 | $0.52 | -37.5% |
| FY2020 | $0.84 | -1.9% |
| FY2019 | $0.85 | +52.2% |
| FY2018 | $0.56 | +314.6% |
| FY2017 | $0.14 | -7.5% |
| FY2016 | $0.15 | -30.8% |
| FY2015 | $0.21 | -53.4% |
As of FY2023 · SEC 10-K Annual Filings · Updated Jun 30, 2026